CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 16 enrolled
Drug / intervention
38% silver diamine fluoridedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04184271
NCT04184271Phase 2Completed
CompareCT.gov

Pharmacokinetics of Advantage Arrest

Advantage Silver Dental Arrest, LLC·interventional·Posted Dec 3, 2019·Updated Jan 26, 2021

In Brief

A Phase 2 clinical trial evaluating 38% silver diamine fluoride for Dental Caries. Completed, enrolled 16 participants across 1 site.

Detailed Summary

The study aim is to characterize the kinetics of silver and fluoride after topical application of silver diamine fluoride.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDental Caries
CountriesUnited States
CollaboratorsUniversity of Washington

Timeline

Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedDec 3, 2019
Enrollment StartAug 1, 2017
Primary CompletionSep 30, 2017
Study CompletionMar 31, 2019
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 6.6 years ago

Interventions

38% silver diamine fluoridedrug

Topical application of SDF to teeth